Efficacy and safety of belimumab for the treatment of refractory childhood-onset systemic lupus erythematosus: A single-center, real-world, retrospective study

Overview of attention for article published in Frontiers in immunology, December 2022

Altmetric Badge

Mentioned by

twitter: 3 X users

Readers on

mendeley: 7 Mendeley

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 50,481 followers.

RT @FrontImmunol: New Research: Efficacy and safety of belimumab for the treatment of refractory childhood-onset systemic lupus erythematos…

15 Dec 2022

Reply Repost Favourite

Efficacy and safety of belimumab for the treatment of refractory childhood-onset systemic lupus erythematosus: A single-center, real-world, retrospective study https://t.co/aCZ188vSIY https://t.co/qoyFjncYYd

14 Dec 2022

Reply Repost Favourite

New Research: Efficacy and safety of belimumab for the treatment of refractory childhood-onset systemic lupus erythematosus: A single-center, real-world, retrospective study: Objective This study aimed to investigate the efficacy and safety… https://t.co/

14 Dec 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.